By contrast, reduction of cGMP/PKG signaling by guanylate cyclase-A gene deletion is reported to develop spontaneous cardiac hypertrophy through TRPC3/6 channel activation (35). The gene discussed is TRPC3; the disease is cardiac hypertrophy.